Mark E. Cooper
Impact in
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
Papers in
- Nephrology 23
- Chronic Kidney Disease and Diabetes 18
- Renal Diseases and Glomerulopathies 6
-
- Diabetes Treatment and Management 9
- Co-authors
- Richard E. Gilbert (5 shared papers)Assam El‐Osta (5 shared papers)Terri J. Allen (9 shared papers)David J. CASLEY (5 shared papers)Zemin Cao (7 shared papers)Annabelle M Warren (2 shared papers)Karin Agnes Maria Jandeleit-Dahm (4 shared papers)Dimitria Vranes (2 shared papers)
- Journals
- Diabetes (14 papers)Kidney International (7 papers)Nature Reviews Nephrology (4 papers)Diabetologia (3 papers)ESMO Open (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark E. Cooper
70 papers receiving 4.9k citations
Mark E. Cooper's Hit Papers
Peers
Comparison fields: 5 of 131
- Nephrology 1.1k
- Clinical Biochemistry 696
- Endocrinology, Diabetes and Metabolism 869
- Cardiology and Cardiovascular Medicine 716
- Physiology 548
Countries citing papers authored by Mark E. Cooper
This map shows the geographic impact of Mark E. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Cooper more than expected).
Fields of papers citing papers by Mark E. Cooper
This network shows the impact of papers produced by Mark E. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Cooper. The network helps show where Mark E. Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New-Onset Diabetes in Covid-19 Hit paper breakdown → | 2020 | 611 |
| 2 | The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Hit paper breakdown → | 1999 | 583 |
| 3 | 1999 | 426 | |
| 4 | 2001 | 325 | |
| 5 | 2019 | 194 | |
| 6 | 2021 | 189 | |
| 7 | 2010 | 182 | |
| 8 | 2015 | 162 | |
| 9 | 2017 | 153 | |
| 10 | 1996 | 137 | |
| 11 | 1994 | 118 | |
| 12 | 2014 | 104 | |
| 13 | 2008 | 98 | |
| 14 | 2001 | 80 | |
| 15 | 2004 | 78 | |
| 16 | 1998 | 78 | |
| 17 | 2018 | 75 | |
| 18 | 2007 | 75 | |
| 19 | 1994 | 74 | |
| 20 | 1997 | 71 |
About Mark E. Cooper
Mark E. Cooper is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Physiology, having authored 72 papers that have together received 5.1k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (18 papers), Diabetes Treatment and Management (9 papers), Renin-Angiotensin System Studies (7 papers), Renal Diseases and Glomerulopathies (6 papers), Advanced Glycation End Products research (6 papers), Pancreatic function and diabetes (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Nitric Oxide and Endothelin Effects (4 papers). The work is most often cited by research in Nephrology (1.1k citations), Clinical Biochemistry (696 citations), Endocrinology, Diabetes and Metabolism (869 citations), Cardiology and Cardiovascular Medicine (716 citations) and Physiology (548 citations). Mark E. Cooper has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Richard E. Gilbert, Assam El‐Osta, Terri J. Allen, David J. CASLEY, Zemin Cao, Annabelle M Warren, Karin Agnes Maria Jandeleit-Dahm, Dimitria Vranes, George Jerums and Søren Tang Knudsen. Their work appears in journals such as Diabetes, Kidney International, Nature Reviews Nephrology, Diabetologia and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.